Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

NCT07133308 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

355

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: Deuruxolitinib
DRUG: Placebo

Sponsor

Sun Pharmaceutical Industries, Inc.